LifeSplice Pharma is an early-stage biotech company that develops extraordinarily specific, potent, and long lasting RNA-based drugs called 'Splice Modulating Oligomers' (SMOs) to treat severe neurological and non-neurological diseases with critical unmet medical needs. The LifeSplice platform technology relies upon innovative and cost-effective in-silico drug design, validated by its founding scientists, that allows for extremely rapid discovery of new SMO product candidates.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Malvern, Pa
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://lifesplicepharma.com
- HQ
- Malvern, PA
Lifesplice Pharma Questions
Lifesplice Pharma's website is http://lifesplicepharma.com
Lifesplice Pharma's LinkedIn profile is https://www.linkedin.com/company/lifesplice-pharma
Lifesplice Pharma has
2 employees.
View email and phone details for 2
employees at Lifesplice Pharma.
Lifesplice Pharma's industry is
Biotechnology Research
Lifesplice Pharma's top competitors are
Jd Bioscience,
Neuroene Therapeutics,
Praxis Precision Medicines, Inc.,
Celosia Therapeutics,
Flobio Llc,
Xenon Pharmaceuticals Inc.,
Boolzi,
Fathom Pharma,
Stridebio, Inc,
Jazz Pharmaceuticals.
Lifesplice Pharma's categories are Biotechnology Research
Lifesplice Pharma's founding year is 2011
